Shan Meng

496 total citations
19 papers, 366 citations indexed

About

Shan Meng is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Shan Meng has authored 19 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Shan Meng's work include Multiple Myeloma Research and Treatments (6 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Shan Meng is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Shan Meng collaborates with scholars based in China, United States and Singapore. Shan Meng's co-authors include Fuling Zhou, Yongchang Wei, Wanggang Zhang, François X. Claret, Hailing Liu, Honglei Tu, Baiyan Wang, Xin Meng, Hui Zhang and Wei Tian and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Nanotechnology.

In The Last Decade

Shan Meng

18 papers receiving 361 citations

Peers

Shan Meng

HEMAT

ONCOL

IMMUN

RNMI

Yongyong Ma China

Sara Nunnery United States

Leszek Kraj Poland

Malte Roerden Germany

Jason Law United States

Maria Niniraki Greece

Emily Littlejohn United States

Rafael Henriques Jácomo Brazil

Ved Chaturvedi India

Ioannis A. Avramis United States

Yongyong Ma China

Shan Meng

84 ×0.4

79 ×0.7

HEMAT

136 ×1.4

ONCOL

39 ×0.5

IMMUN

24 ×0.6

RNMI

Citations per year, relative to Shan Meng Shan Meng (= 1×) peers Yongyong Ma

Countries citing papers authored by Shan Meng

Since Specialization

Citations

This map shows the geographic impact of Shan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Meng more than expected).

Fields of papers citing papers by Shan Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Meng. The network helps show where Shan Meng may publish in the future.

Co-authorship network of co-authors of Shan Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Meng. A scholar is included among the top collaborators of Shan Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Meng. Shan Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Meng, Shan, Yesheng Wang, Casey M. Platnich, et al.. (2025). Nanopore detection of single-nucleotide RNA mutations and modifications with programmable nanolatches. Nature Nanotechnology. 20(10). 1473–1481.

Zhu, C. G., Dunfang Zhang, Shan Meng, et al.. (2025). CCR8 ⁺ decidual regulatory T cells maintain maternal-fetal immune tolerance during early pregnancy. Science Immunology. 10(106). eado2463–eado2463. 4 indexed citations

Deng, Meng, Yuwen Ma, Yang Yu, et al.. (2025). LncRNA CTD-2555A7.2 promotes bone formation with LncRNA-specific cascade amplification strategy. Scientific Reports. 15(1). 20687–20687. 2 indexed citations

Zeng, Beilei, et al.. (2024). Brain radiation necrosis treated with bevacizumab in a patient with advanced squamous cell lung carcinoma: A case report. Oncology Letters. 29(2). 98–98. 1 indexed citations

Meng, Shan, Huiying Qiu, Suning Chen, et al.. (2022). The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 13. 843067–843067. 6 indexed citations

Meng, Shan, Yutong Lu, Peng Wang, et al.. (2021). Characteristics and transplant outcome of myeloid sarcoma: a single-institute study. International Journal of Hematology. 113(5). 682–692. 9 indexed citations

Wang, Peng, Shan Meng, Shijia Li, et al.. (2021). Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients. Frontiers in Oncology. 11. 803994–803994. 5 indexed citations

Zhou, Fuling, Yunbao Pan, Yongchang Wei, et al.. (2017). Jab1/Csn5–Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clinical Cancer Research. 23(15). 4450–4461. 52 indexed citations

Liu, Hailing, Yunbao Pan, Shan Meng, Wanggang Zhang, & Fuling Zhou. (2017). Current treatment options of T cell-associated immunotherapy in multiple myeloma. Clinical and Experimental Medicine. 17(4). 431–439. 7 indexed citations

10.

Meng, Shan, Yanxia Jin, Wanggang Zhang, et al.. (2017). A novel multi‐epitope vaccine from MMSA‐1 and DKK1 for multiple myeloma immunotherapy. British Journal of Haematology. 178(3). 413–426. 49 indexed citations

11.

Meng, Shan, Zhuo Ma, Hailing Liu, et al.. (2017). Prognostic Value of Elevated Red Blood Cell Distribution Width in Chinese Patients with Multiple Myeloma.. PubMed. 47(3). 282–290. 23 indexed citations

12.

Tu, Honglei, Bo Lei, Shan Meng, et al.. (2016). Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia. Evidence-based Complementary and Alternative Medicine. 2016(1). 3121402–3121402. 16 indexed citations

13.

Li, Chuanming, Shan Meng, Xinhua Yang, et al.. (2015). Sentinel lymph node detection using magnetic resonance lymphography with conventional gadolinium contrast agent in breast cancer: a preliminary clinical study. BMC Cancer. 15(1). 213–213. 16 indexed citations

14.

Meng, Shan, Wanggang Zhang, Wen‐Jun Shen, et al.. (2015). MMSA-1 expression pattern in multiple myeloma and its clinical significance. Clinical and Experimental Medicine. 16(4). 599–609. 6 indexed citations

15.

Li, Chuanming, Shan Meng, Xinhua Yang, Jian Wang, & Jiani Hu. (2014). The Value of T2* in Differentiating Metastatic from Benign Axillary Lymph Nodes in Patients with Breast Cancer - A Preliminary In Vivo Study. PLoS ONE. 9(1). e84038–e84038. 19 indexed citations

16.

Meng, Shan, et al.. (2014). A New Technique to Map the Lymphatic Distribution and Alignment of the Penis. The Anatomical Record. 298(8). 1465–1471. 3 indexed citations

17.

Zhou, Fuling, et al.. (2013). Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention. Blood Reviews. 27(6). 261–267. 47 indexed citations

18.

Zhou, Fuling, Wanggang Zhang, Yongchang Wei, et al.. (2010). Involvement of Oxidative Stress in the Relapse of Acute Myeloid Leukemia. Journal of Biological Chemistry. 285(20). 15010–15015. 91 indexed citations

19.

Zhou, Fuling, et al.. (2010). Peptide-based immunotherapy for multiple myeloma: Current approaches. Vaccine. 28(37). 5939–5946. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact